Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Bighelli

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|November 1, 2024
Developing STEP-SE: A Qualitative Usability Study of a Novel Patient-Reported Outcomes Tool for Managing Side Effects in Shared Decision-Making for Schizophrenia Spectrum Disorder CareAlessandro Rodolico, Antonio Di Francesco, Pierfelice Cutrufelli, et al.
Molecular Autism|March 5, 2022
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysisSpyridon Siafis, Oğulcan Çıray, Hui Wu, et al.
Eclinicalmedicine|November 10, 2025
Non-invasive brain stimulation augmentation therapy for treatment-resistant schizophrenia: a systematic review and network meta-analysisYaohui Wei, Carolin Lorenz, Spyridon Siafis, et al.
Lancet (London, England)|February 28, 2026
Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databasesJohannes Schneider-Thoma, Yikang Zhu, Mengchang Qin, et al.
BMJ Open|May 7, 2013
INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocolClaudia Goss, Alberto Ghilardi, Giuseppe Deledda, et al.
The Lancet. Psychiatry|March 1, 2025
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysisJohannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, et al.
F1000Research|January 23, 2025
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysisSpyridon Siafis, Nobuyuki Nomura, Johannes Schneider-Thoma, et al.
The Lancet. Psychiatry|June 8, 2026
Comparative effectiveness and safety of pharmacological treatments for rapid tranquilisation in emergency settings: a systematic review and individual participant data network meta-analysisSpyridon Siafis, Frederik Philipona, Nobuyuki Nomura, et al.
The Lancet. Psychiatry|December 3, 2023
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysisSpyridon Siafis, Lasse Brandt, Robert A McCutcheon, et al.
Systematic Reviews|August 2, 2024
Effectiveness of pharmacological treatments for severe agitation in real-world emergency settings: protocol of individual-participant-data network meta-analysisSpyridon Siafis, Hui Wu, Nobuyuki Nomura, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|November 1, 2024
Developing STEP-SE: A Qualitative Usability Study of a Novel Patient-Reported Outcomes Tool for Managing Side Effects in Shared Decision-Making for Schizophrenia Spectrum Disorder CareAlessandro Rodolico, Antonio Di Francesco, Pierfelice Cutrufelli, et al.
Molecular Autism|March 5, 2022
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysisSpyridon Siafis, Oğulcan Çıray, Hui Wu, et al.
Eclinicalmedicine|November 10, 2025
Non-invasive brain stimulation augmentation therapy for treatment-resistant schizophrenia: a systematic review and network meta-analysisYaohui Wei, Carolin Lorenz, Spyridon Siafis, et al.
Lancet (London, England)|February 28, 2026
Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databasesJohannes Schneider-Thoma, Yikang Zhu, Mengchang Qin, et al.
BMJ Open|May 7, 2013
INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocolClaudia Goss, Alberto Ghilardi, Giuseppe Deledda, et al.
The Lancet. Psychiatry|March 1, 2025
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysisJohannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, et al.
F1000Research|January 23, 2025
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysisSpyridon Siafis, Nobuyuki Nomura, Johannes Schneider-Thoma, et al.
The Lancet. Psychiatry|June 8, 2026
Comparative effectiveness and safety of pharmacological treatments for rapid tranquilisation in emergency settings: a systematic review and individual participant data network meta-analysisSpyridon Siafis, Frederik Philipona, Nobuyuki Nomura, et al.
The Lancet. Psychiatry|December 3, 2023
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysisSpyridon Siafis, Lasse Brandt, Robert A McCutcheon, et al.
Systematic Reviews|August 2, 2024
Effectiveness of pharmacological treatments for severe agitation in real-world emergency settings: protocol of individual-participant-data network meta-analysisSpyridon Siafis, Hui Wu, Nobuyuki Nomura, et al.
Pageof 9